Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence-based Social Software Management Model to Improve Warfarin Anticoagulation Therapy: a Prospective, Single-blind, Randomized Control Trial

NCT03870581 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.

NCT NCT03870581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03870581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence-based Social Software Management Model to Improve Warfarin Anticoagulation Therapy: a Prospective, Single-blind, Randomized Control Trial
Lead sponsor
Wuhan Asia Heart Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2019
Completion date
May 1, 2021
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, warfarin sodium causing adverse effects in therapeutic use